Growth Metrics

Merck (MRK) Return on Capital Employed Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 2,293.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 952.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 164.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -438.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 154.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 453.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -2,699.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -497.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -438.00
Dec 31, 2025 562.00
Sep 30, 2025 821.00
Jun 30, 2025 282.00
Mar 31, 2025 567.00
Dec 31, 2024 500.00
Sep 30, 2024 894.00
Jun 30, 2024 1,351.00
Mar 31, 2024 -209.00
Dec 31, 2023 -596.00
Sep 30, 2023 -638.00
Jun 30, 2023 -611.00
Mar 31, 2023 624.00
Dec 31, 2022 671.00
Sep 30, 2022 323.00
Jun 30, 2022 471.00
Mar 31, 2022 456.00
Dec 31, 2021 813.00
Sep 30, 2021 -221.00
Jun 30, 2021 -214.00
Mar 31, 2021 -222.00
Dec 31, 2020 -264.00
Sep 30, 2020 917.00
Jun 30, 2020 291.00
Mar 31, 2020 404.00
Dec 31, 2019 391.00
Sep 30, 2019 536.00
Jun 30, 2019 738.00
Mar 31, 2019 662.00
Dec 31, 2018 379.00
Sep 30, 2018 -1,040.00
Jun 30, 2018 -1,185.00
Mar 31, 2018 -1,043.00
Dec 31, 2017 -961.00
Sep 30, 2017 152.00
Jun 30, 2017 333.00
Mar 31, 2017 166.00
Dec 31, 2016 118.00
Sep 30, 2016 301.00
Jun 30, 2015 875.00
Mar 31, 2015 1,001.00
Dec 31, 2014 1,128.00
Sep 30, 2014 -133.00
Jun 30, 2014 262.00
Mar 31, 2014 327.00
Dec 31, 2013 -33.00
Sep 30, 2013 -326.00